Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

MTRAC Reviews - December 2014

MTRAC issued an updated Commissioning Support guidance in December 2014. The review covers fluticasone / formoterol inhaler.

The fluticasone / formoterol inhaler (Flutiform®) summary advises that this combination inhaled corticosteroid / long-acting beta agonist inhaler is suitable for prescribing in primary care for the treatment of asthma. It is noted that in two 12-week RCTs, flutiform was found to be non-inferior to a fluticasone / salmeterol inhaler (Seretide®), and a budesonide / formoterol inhaler (Symbicort®) respectively for the primary outcome of change in pre-dose FEV1 from baseline.

Action: Clinicians should be aware of these reviews and use the recommendations to guide appropriate use of these medicines in current practice.

Share 'MTRAC Reviews - December 2014' on Email Share 'MTRAC Reviews - December 2014' on Delicious Share 'MTRAC Reviews - December 2014' on Digg Share 'MTRAC Reviews - December 2014' on Facebook Share 'MTRAC Reviews - December 2014' on reddit Share 'MTRAC Reviews - December 2014' on StumbleUpon Share 'MTRAC Reviews - December 2014' on Twitter

atomic-wealth

No Comments to “MTRAC Reviews - December 2014”

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.

atomic-wealth
fond-illness
summer